Ischemic stroke is characterized by a range of peculiarities to which belong not only primary but also secondary injuries that depend on the dislocation of cerebral structures. General morphological functional integrity of neural tissue is distorted. Existing range of pharmaceutical preparations of neuroprotective profile does not satisfy current needs in treatment of ischemic strokes. Density of neurons, glia cells, apoptotic and destructive neurons, square of neurocytons, apoptotic and destructive changed neurons, concentration of RNA in neurons have been defined.
